MedTrace Logo

Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression

NCT02625779 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-02-09

No results posted yet for this study

Summary

This research is aimed to investigate the efficacy and safety of the creatine and cytidine augmentation in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using proton and phosphorous magnetic resonance spectroscopy.

Conditions

  • Depression, Bipolar

Interventions

DRUG

Valproate and Placebo

DRUG

Valproate and Cytidine-containing Drug

DRUG

Valproate and Creatine-containing Drug

Sponsors & Collaborators

  • Ewha Womans University Mokdong Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02625779 on ClinicalTrials.gov